OCT 22, 2026 · JOURNAL ARTICLE
Comparative Analysis of TIGIT / CD155 Inhibitors in Cancer: Small Molecules, Antibodies, and Emerging Modalities
Journal of Molecular Recognition
ABSTRACT Following the rise in resistance to PD‐1/PD‐L1 immune checkpoint blockade therapy in patients with cancer, the TIGIT/CD155 axis has emerged as a major focus of current res